News
RBII
0.0000
NaN%
--
Weekly Report: what happened at RBII last week (1208-1212)?
Weekly Report · 1d ago
Weekly Report: what happened at RBII last week (1201-1205)?
Weekly Report · 12/08 10:10
Weekly Report: what happened at RBII last week (1124-1128)?
Weekly Report · 12/01 10:06
Weekly Report: what happened at RBII last week (1117-1121)?
Weekly Report · 11/24 10:11
Weekly Report: what happened at RBII last week (1110-1114)?
Weekly Report · 11/17 10:11
Weekly Report: what happened at RBII last week (1103-1107)?
Weekly Report · 11/10 10:08
Weekly Report: what happened at RBII last week (1027-1031)?
Weekly Report · 11/03 10:09
Weekly Report: what happened at RBII last week (1020-1024)?
Weekly Report · 10/27 10:11
Weekly Report: what happened at RBII last week (1013-1017)?
Weekly Report · 10/20 10:08
Weekly Report: what happened at RBII last week (1006-1010)?
Weekly Report · 10/13 10:11
Weekly Report: what happened at RBII last week (0929-1003)?
Weekly Report · 10/06 10:08
Weekly Report: what happened at RBII last week (0922-0926)?
Weekly Report · 09/29 10:08
Weekly Report: what happened at RBII last week (0915-0919)?
Weekly Report · 09/22 10:08
Weekly Report: what happened at RBII last week (0908-0912)?
Weekly Report · 09/15 10:37
Weekly Report: what happened at RBII last week (0901-0905)?
Weekly Report · 09/08 10:39
Weekly Report: what happened at RBII last week (0825-0829)?
Weekly Report · 09/01 10:35
Weekly Report: what happened at RBII last week (0818-0822)?
Weekly Report · 08/25 10:43
Weekly Report: what happened at RBII last week (0811-0815)?
Weekly Report · 08/18 10:37
Weekly Report: what happened at RBII last week (0804-0808)?
Weekly Report · 08/11 10:43
Weekly Report: what happened at RBII last week (0728-0801)?
Weekly Report · 08/04 10:45
More
Webull provides a variety of real-time RBII stock news. You can receive the latest news about Rising Biosciences through multiple platforms. This information may help you make smarter investment decisions.
About RBII
Rising Biosciences, Inc. is a research and development company. The Company is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The Company operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physician’s practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.